Key result
Normoglycemic first-degree relatives of diabetics exhibit early vascular dysfunction that worsens with disease advancement.
Why the study?
The study was designed to delineate the point of vascular dysfunction across the glycemic spectrum, from normoglycemic individuals with or without a family history of diabetes to prediabetic and diabetic individuals.
Does vascular function deteriorate across the glycemic spectrum from normoglycemia to diabetes?
Cross-Sectional (n=252)
Does vascular function deteriorate across the glycemic spectrum from normoglycemia to diabetes?
Vascular endothelial dysfunction, indicated by biomarker derangement, precedes clinical prediabetes and is detectable in normoglycemic individuals with a family history of diabetes.
Answers are grounded in this paper and cite their sources.
May flag familial vascular risk before dysglycemia; hypothesis-generating and requires prospective validation before clinical use.
Purpose: The present study was conceived to delineate the point of vascular dysfunction along the glycemic spectrum (normoglycemic individuals with no family history of diabetes, normoglycemic individuals with family history of diabetes, prediabetic individuals, and diabetic individuals).Materials and Methods: In this cross-sectional comparative study, we enrolled 252 participants of both gender in the age group of 30–50 years. They were classified based on their family history of diabetes and glycemic status into four groups along the glycemic spectrum as mentioned above. We measured flow-mediated dilation (FMD) from brachial artery and vascular function biomarkers such as enthothelin-1 (ET-1), von Willbrand Factor (vWF), Vascular Endothelial Growth Factor (VEGF) to assess the vascular function. The comparison of data between groups were done using One Way ANOVA/Kruskal–Wallis followed by post-hoc analysis using LSD/Mann–Whitney U Test depending on the normality of the data. Spearman correlation was done between vascular function and plasma glucose levels to identify its relationship. Linear regression was carried out to identify the factors influencing the FMD across the glycemic spectrum.Results: We observed that vascular function negatively correlated with blood glucose levels. However, endothelin-1 and vWF derangement was there even in normoglycemic first degree relatives of diabetes (FDRD) and the derangement increased in prediabetes and diabetes. Physiological dysfunction in terms of decreased flow-mediated dilation starts from prediabetes only. VEGF derangement is found only in diabetic individuals.Conclusion: Vascular dysfunction is found even in normoglycemic FDRD and the derangement increased and compounded with the advancement of disease.
No takes yet. Share an insight, caveat, or question.
Rajendran et al. (2021) conducted a cross-sectional in Glycemic spectrum (normoglycemic, prediabetic, diabetic) (n=252). Glycemic status and family history of diabetes vs. Normoglycemic individuals with no family history of diabetes was evaluated on Vascular function assessed by flow-mediated dilation (FMD), endothelin-1 (ET-1), von Willebrand Factor (vWF), and Vascular Endothelial Growth Factor (VEGF). Vascular dysfunction, indicated by endothelin-1 and vWF derangement, was present even in normoglycemic first-degree relatives of diabetics and worsened with disease advancement.
Synapse has enriched 10 related papers. Consider them for comparative context: